Home »  Tranzyme Technology » INTEGRATED DRUG DISCOVERY Integrating Functional Biology and Medicinal Chemistry for the Development of Novel Pharmaceuticals Tranzyme Pharma’s proprietary technologies in medicinal chemistry and functional biology enable a powerful, integrated strategy for the discovery and development of new pharmaceutical products. These technologies are applicable to a broad range of targets, including two of the most relevant classes for pharmaceutical development, G protein-coupled receptors (GPCRs) and protein kinases. This combination of chemistry and biology provides competitive advantages to accelerate drug discovery and development.   MATCH™ - Macrocyclic Template Chemistry Robust synthetic methods for rapid hit-to-clinic optimization of the Company's macrocyclic small molecules. Details »   HitCREATE™ Library A library of over 25,000 distinct macrocyclic small molecules that captures diverse spatial topology and functionality. Details »   TExT™ - TranzExpression Technology Introduction of functional biology capabilities in all phases of the drug discovery process though high-content screening, assay development, and animal models of disease. Details »